LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026
Rhea-AI Summary
LeMaitre (Nasdaq: LMAT) will release its second quarter 2026 financial results on Tuesday, August 4, 2026, after the market close. The company will host a conference call at 5:00 PM EDT the same day to review results, business highlights, and outlook.
Investors can access the live call by registering online to receive dial-in details and a PIN. An audio webcast, including a replay, will be available at ir.lemaitre.com.
Positive
- None.
Negative
- None.
News Market Reaction – LMAT
In the Jul 15 session, LMAT gained 1.97%, reflecting a mild positive market reaction. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 14 | Earnings date notice | Neutral | -2.2% | Announced Q1 2026 results date with post-close call and webcast details. |
| Feb 11 | Earnings date notice | Neutral | -0.2% | Set Q4 2025 results release date and 5:00 PM EST conference call. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Past earnings-date notices for LeMaitre have been followed by modestly negative one-day moves on average.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2026 financial results on Tuesday, August 4, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook.
Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay at ir.lemaitre.com.
About LeMaitre
LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.

Contact: Gregory Manker Director, Business Development & Investor Relations LeMaitre Vascular, Inc. +1 781-362-1260 gmanker@lemaitre.com